MATCH Arm EAY131-J

**Semantic type:** Intellectual Product

**Definition:** The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with trastuzumab and pertuzumab in patients with cancers that have ERBB2 (HER2) amplifications, excluding breast cancers, colorectal cancers, gastric cancers and gastroesophageal junction (GEJ) cancers.

**Synonyms:** - EAY131-J - J